前のページに戻る
この文献は全文を取り寄せることができます
JDreamⅢ複写サービスから文献全文の複写（冊子体のコピー）をお申込みできます。
ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です。
ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です。
既に、G-Searchデータベースサービスまたは、JDreamⅢのIDをお持ちの方
JDreamⅢ複写サービスのご利用が初めての方
取り寄せる文献のタイトルと詳細
文献
J-GLOBAL ID：201702280417643725
整理番号：17A0317169
癌における薬理ゲノム学的相互作用の景観【Powered by NICT】
A Landscape of Pharmacogenomic Interactions in Cancer
Iorio Francesco
(European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Cambridge CB10 1SA, UK)
,
Iorio Francesco
(Wellcome Trust Sanger Institute, Wellcome Genome Campus, Cambridge CB10 1SA, UK)
,
Knijnenburg Theo A.
(Institute for Systems Biology, Seattle, WA 98109, USA)
,
Knijnenburg Theo A.
(Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam 1066 CX, The Netherlands)
,
Vis Daniel J.
(Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam 1066 CX, The Netherlands)
,
Bignell Graham R.
(Wellcome Trust Sanger Institute, Wellcome Genome Campus, Cambridge CB10 1SA, UK)
,
Menden Michael P.
(European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Cambridge CB10 1SA, UK)
,
Menden Michael P.
(Faculty of Medicine, Joint Research Centre for Computational Biomedicine, RWTH Aachen University, Aachen 52057, Germany)
,
Schubert Michael
(European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Cambridge CB10 1SA, UK)
,
Aben Nanne
(Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam 1066 CX, The Netherlands)
,
Aben Nanne
(Department of EEMCS, Delft University of Technology, Delft 2628 CD, the Netherlands)
,
Goncalves Emanuel
(European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Cambridge CB10 1SA, UK)
,
Barthorpe Syd
(Wellcome Trust Sanger Institute, Wellcome Genome Campus, Cambridge CB10 1SA, UK)
,
Lightfoot Howard
(Wellcome Trust Sanger Institute, Wellcome Genome Campus, Cambridge CB10 1SA, UK)
,
Cokelaer Thomas
(European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Cambridge CB10 1SA, UK)
,
Cokelaer Thomas
(Wellcome Trust Sanger Institute, Wellcome Genome Campus, Cambridge CB10 1SA, UK)
,
Greninger Patricia
(Center for Cancer Research, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129, USA)
,
van Dyk Ewald
(Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam 1066 CX, The Netherlands)
,
Chang Han
(Genetically Defined Diseases and Genomics, Bristol-Myers Squibb Research and Development, Hopewell, NJ 08534, USA)
,
de Silva Heshani
(Genetically Defined Diseases and Genomics, Bristol-Myers Squibb Research and Development, Hopewell, NJ 08534, USA)
,
Heyn Holger
(Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet 08908, Barcelona, Catalonia, Spain)
,
Deng Xianming
(Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA)
,
Deng Xianming
(Department of Biological Chemistry & Molecular Pharmacology, Harvard Medical School, Boston, MA 02215, USA)
,
Egan Regina K.
(Center for Cancer Research, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129, USA)
,
Liu Qingsong
(Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA)
,
Liu Qingsong
(Department of Biological Chemistry & Molecular Pharmacology, Harvard Medical School, Boston, MA 02215, USA)
,
Mironenko Tatiana
(Wellcome Trust Sanger Institute, Wellcome Genome Campus, Cambridge CB10 1SA, UK)
,
Mitropoulos Xeni
(Center for Cancer Research, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129, USA)
,
Richardson Laura
(Wellcome Trust Sanger Institute, Wellcome Genome Campus, Cambridge CB10 1SA, UK)
,
Wang Jinhua
(Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA)
,
Wang Jinhua
(Department of Biological Chemistry & Molecular Pharmacology, Harvard Medical School, Boston, MA 02215, USA)
,
Zhang Tinghu
(Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA)
,
Zhang Tinghu
(Department of Biological Chemistry & Molecular Pharmacology, Harvard Medical School, Boston, MA 02215, USA)
,
Moran Sebastian
(Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet 08908, Barcelona, Catalonia, Spain)
,
Sayols Sergi
(Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet 08908, Barcelona, Catalonia, Spain)
,
Soleimani Maryam
(Wellcome Trust Sanger Institute, Wellcome Genome Campus, Cambridge CB10 1SA, UK)
,
Tamborero David
(Research Program on Biomedical Informatics, IMIM Hospital del Mar Medical Research Institute and Universitat Pompeu Fabra, Barcelona 08003, Spain)
,
Lopez-Bigas Nuria
(Research Program on Biomedical Informatics, IMIM Hospital del Mar Medical Research Institute and Universitat Pompeu Fabra, Barcelona 08003, Spain)
,
Lopez-Bigas Nuria
(Institucio Catalana de Recerca i Estudis Avancats (ICREA), 08010 Barcelona, Catalonia, Spain)
,
Ross-Macdonald Petra
(Genetically Defined Diseases and Genomics, Bristol-Myers Squibb Research and Development, Hopewell, NJ 08534, USA)
,
Esteller Manel
(Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), L’Hospitalet 08908, Barcelona, Catalonia, Spain)
,
Esteller Manel
(Institucio Catalana de Recerca i Estudis Avancats (ICREA), 08010 Barcelona, Catalonia, Spain)
,
Esteller Manel
(Department of Physiological Sciences II of the School of Medicine, University of Barcelona, L’Hospitalet 08908, Barcelona, Catalonia, Spain)
,
Gray Nathanael S.
(Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA)
,
Gray Nathanael S.
(Department of Biological Chemistry & Molecular Pharmacology, Harvard Medical School, Boston, MA 02215, USA)
,
Haber Daniel A.
(Center for Cancer Research, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129, USA)
,
Haber Daniel A.
(Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA)
,
Stratton Michael R.
(Wellcome Trust Sanger Institute, Wellcome Genome Campus, Cambridge CB10 1SA, UK)
,
Benes Cyril H.
(Center for Cancer Research, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129, USA)
,
Wessels Lodewyk F.A.
(Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam 1066 CX, The Netherlands)
,
Wessels Lodewyk F.A.
(Department of EEMCS, Delft University of Technology, Delft 2628 CD, the Netherlands)
,
Wessels Lodewyk F.A.
(Cancer Genomics Netherlands, Uppsalalaan 8, Utrecht 3584CT, the Netherlands)
,
Saez-Rodriguez Julio
(European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Cambridge CB10 1SA, UK)
,
Saez-Rodriguez Julio
(Faculty of Medicine, Joint Research Centre for Computational Biomedicine, RWTH Aachen University, Aachen 52057, Germany)
,
McDermott Ultan
(Wellcome Trust Sanger Institute, Wellcome Genome Campus, Cambridge CB10 1SA, UK)
,
Garnett Mathew J.
(Wellcome Trust Sanger Institute, Wellcome Genome Campus, Cambridge CB10 1SA, UK)
資料名：
Cell (Cambridge, Mass.)
(Cell (Cambridge, Mass.))
巻： 166 号： 3 ページ： 740-754 発行年： 2016年
JST資料番号： A0707B ISSN： 0092-8674 資料種別： 逐次刊行物 (A)
記事区分： 原著論文 発行国： アメリカ合衆国 (USA) 言語： 英語 (EN)
JDreamⅢ複写サービスとは
JDreamⅢ複写サービスは、学術文献の全文を複写（コピー）して取り寄せできる有料サービスです。インターネットに公開されていない文献や、図書館に収録されていない文献の全文を、オンラインで取り寄せることができます。J-GLOBALの整理番号にも対応しているので、申し込みも簡単にできます。全文の複写（コピー）は郵送またはFAXでお送りします
※ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です
※初めてご利用される方は、JDreamⅢ複写サービスのご案内をご覧ください。
※ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です
※初めてご利用される方は、JDreamⅢ複写サービスのご案内をご覧ください。